[1] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2022)[J].中国全科医学,2023,26(14):1671-1691. [2] 中华医学会骨质疏松和骨矿盐疾病分会. 中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(4):317-318. [3] 张保良,陈仲强. 骨质疏松性椎体压缩骨折分型及分级系统研究进展[J].中国骨质疏松杂志,2021,27(4):590-594. [4] COUGHLAN T, DOCKERY F. Osteoporosis and fracture risk in older people[J]. Clin Med: Lond, 2014, 14(2):187-191. [5] 中华医学会骨质疏松和骨矿盐疾病分会. 骨质疏松性椎体压缩性骨折诊疗与管理专家共识[J]. 中华骨质疏松和骨矿盐疾病杂志,2018,11(5):425-437. [6] 中国医师协会骨科学分会脊柱创伤专业委员会. 急性症状性骨质疏松性胸腰椎压缩骨折椎体强化术临床指南[J].中华创伤杂志,2019,35(6):481-489. [7] 《中国定量CT(QCT)骨质疏松症诊断指南》工作组,程晓光,王亮,等. 中国定量CT(QCT)骨质疏松症诊断指南(2018)[J]. 中国骨质疏松杂志,2019,25(6):733-737. [8] 郑光新,赵晓鸥,刘广林,等. Oswestry功能障碍指数评定腰痛患者的可信性[J].中国脊柱脊髓杂志,2002, 12(1):13-15. [9] BU D, HE X. Comparison of different approaches of percutaneous vertebroplasty in the treatment of osteoporotic spinal compression fractures and analysis of influencing factors of re-fracture[J]. Pak J Med Sci, 2023, 39(1):144-149. [10] 刘芳,肖志宏,黄兰香. 两种不同入路PVP治疗骨质疏松性椎体压缩骨折患者的效果比较[J].中外医学研究,2023,21(5): 30-33. [11] DAI H, LIU Y, HAN Q, et al. Biomechanical comparison between unilateral and bilateral percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a finite element analysis[J]. Front Bioeng Biotechnol, 2022, 10:978917. [12] 包利帅,吴伟,钟喜红,等. 骨水泥分布对单侧经椎弓根穿刺治疗脊柱骨质疏松骨折临床效果的影响[J].中国骨伤,2022,35(5):423-429. [13] ZHOU C, LIAO Y, HUANG S, et al. Effect of cement distribution type on clinical outcome after percutaneous vertebroplasty for osteoporotic vertebral compression fractures in the aging population[J].Front Surg,2022,9: 975832. [14] 吴溢峰,钟姣红,吴焯鹏,等. 3种不同入路经皮椎体成形术治疗胸腰段椎体压缩性骨折的疗效比较[J].中国微创外科杂志,2018,18(7):611-615. [15] 王梦然,傅智轶,王惠东,等. 不同骨水泥剂量经皮椎体成形术治疗骨质疏松性胸腰椎压缩性骨折[J].脊柱外科杂志, 2020, 18(4):217-221, 236. [16] 刘展亮,张惠城,陈嘉裕,等. 经皮椎体成形术中骨水泥注射量与疗效的关系[J].广东医学,2010,31(4): 444-446. [17] 梁锐康,笪晓伟,区杰雄,等. 经皮椎体成形术中不同骨水泥注入量治疗骨质疏松性椎体压缩性骨折的效果比较[J].现代医学与健康研究电子杂志,2023,7(4):51-53. [18] 上官文峰,欧阳利云,任国梁,等. 不同剂量骨水泥灌注单侧经皮椎体成形术治疗骨质疏松性胸腰椎压缩性骨折患者的疗效对比分析[J].临床研究,2023,31(1):67-70. [19] 张会如. 中老年人腰椎椎体CT测量及临床意义[J].中国医学装备,2016,13(4):61-64. [20] LIMTHONGKUL W, KARAIKOVIC E E, SAVAGE J W, et al. Volumetric analysis of thoracic and lumbar vertebral bodies[J]. Spine J, 2010, 10(2):153-158. [21] 廖芝富,匡中强,曲诗言,等. 经皮椎体成形术后邻近椎体继发骨折危险因素分析[J].中国骨与关节杂志,2023,12(4):296-301. [22] 王彭,张德光. 经皮椎体成形术骨水泥渗漏对椎体压缩骨折术后邻近椎体骨折的影响及相关性研究[J].颈腰痛杂志,2021,42(6):787-789. [23] DAI C, LIANG G, ZHANG Y,et al. Risk factors of vertebral re-fracture after PVP or PKP for osteoporotic vertebral compression fractures, especially in Eastern Asia: a systematic review and meta-analysis[J]. J Orthop Surg Res,2022,17(1):161. [24] NOGUCHI T, YAMASHITA K, KAMEI R,et al. Current status and challenges of percutaneous vertebroplasty (PVP)[J]. Jpn J Radiol, 2023, 41(1):1-13. [25] LI Y X, GUO D Q, ZHANG S C,et al. Risk factor analysis for re-collapse of cemented vertebrae after percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP)[J]. Int Orthop, 2018, 42(9): 2131-2139. [26] QIAN L,CHEN Q,WANG D,et al. Study on the relationship between the use of bisphosphonates for antiosteoporosis and vertebral re-fracture after vertebroplasty[J].Evid Based Complement Alternat Med,2022,2022:3223437. |